InnovAge Holding (INNV) Gains from Sales and Divestitures (2022)
InnovAge Holding (INNV) reported Gains from Sales and Divestitures of $844081.0 for Q4 2022, up 1538.39% quarter-over-quarter from $51519.0 in Q3 2022.
InnovAge Holding (INNV) Gains from Sales and Divestitures (2022) Analysis & Trends
InnovAge Holding has reported Gains from Sales and Divestitures for 1 years, with the latest figure at $844081.0 in Q4 2022.
- For the quarter ending Q4 2022, Gains from Sales and Divestitures changed N/A year-over-year to $844081.0; the trailing twelve-month figure through Dec 2022 stood at $844081.0 (changed N/A YoY), and the FY2022 full-year result was $1.6 million, changed N/A from the prior year.
- Gains from Sales and Divestitures for Q4 2022 stood at $844081.0, up from $51519.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $1.6 million in Q2 2022, with the low at $51519.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn |
| 10 | InnovAge Holding | 1.21 Bn | 1.12 Bn | 243.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 844,081.00 |
| Dec 31, 2022 | 844,081.00 |
| Sep 30, 2022 | 51,519.00 |
| Sep 30, 2022 | 51,519.00 |
| Jun 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 1.62 Mn |